Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor NJ 08520 NDC # 55150-306-10
Published January 15, 2025 · Recall initiated: December 27, 2024
Summary
FDA records drug Class II recall D-0186-2025, published January 15, 2025 and initiated December 27, 2024. Recalling firm: Eugia US LLC; Status: Ongoing; Reported quantity: 17,300 10-mL vials; Lot: Batch # 1PR24010, Expiry: 02/28/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.
What to do
Voluntary: Firm initiated · Letter
Get an email if PROGESTERONE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PROGESTERONE
- Manufacturer
- Eugia US LLC
- Distributor
- Distributed Nationwide in the USA.
- Lot
- Batch # 1PR24010, Expiry: 02/28/2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAmedroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL, Rx only, 1 mL Single-Dose Vial, Mfd inJanuary 15, 2025
- FDAColchicine Capsules 0.6 mg, 30-count bottles, Rx only, Manufactured by: Granules Pharmaceuticals Inc.January 15, 2025
- FDAClobazam Tablets, 10 mg, packaged in 30 tablets per carton (3x10 blister cards each), Rx Only, AmnealJanuary 15, 2025
- FDADuloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000 count (NDCJanuary 15, 2025
- FDAProgesterone Injection, USP, 500 mg per 10 mL (50mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Mfd. in India for:August 7, 2024
- FDAProgesterone Capsules, 200 mg, 100-count bottles, Rx Only, MADE IN FRANCE; Distributed by: Dr. Reddy'sMarch 10, 2021
Questions about this recall
Was Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor NJ 08520 NDC # 55150-306-10 recalled?
Yes. FDA published recall D-0186-2025 on January 15, 2025. Reported hazard: Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PROGESTERONE.